Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by besttobeon May 30, 2021 11:03am
123 Views
Post# 33294016

RE:RE:RE:RE:RE:RE:RE:RE:Bad news/ Good news

RE:RE:RE:RE:RE:RE:RE:RE:Bad news/ Good newsTodd Zehnder

"Yes, I think that your EBITDA margins will be back to normal for the rest of the year, really, and that’s going to—that will immediately come back to us. I think, G&A, we said it’s going to be flat for the rest of the year. For Q2, it very well could be down some, just like we had last year. I think it was 3Q was underneath what Q2 came in. We are going to have less phantom expense in the third quarter—I mean, the second quarter than we did the first, but you’re right, we’re going to have some other initiatives that things are ramping back up"
<< Previous
Bullboard Posts
Next >>